This year’s programme is currently under development. Our speaker line-up will be published soon.
| Sun-Jane Wang |
Assoc. Dir., Adaptive Design |
FDA |
| Prof Bruno Flamion |
Federal Agency for Medicines and Health Products (FAMHP) |
Belgium |
| Dr Solange Rohou |
Director European Regulatory Affairs |
AstraZeneca |
| Alun Bedding |
Director |
GSK |
| Ingvild Aaløkken |
Head of Section |
Norwegian Medicines Agency(NMA) |
| Professor Andy Grieve |
Department of Public Health Sciences |
King’s College London |
| Catarina Mattsson |
Clinical Project Manager |
AstraZeneca |
| Pavel Pisa |
Translational Medicine Leader |
Roche |
| Philip De Ridder |
Director |
Johnson and Johnson |
| (speaker to be confirmed) |
|
Health Canada |
| Dr Patrick Johnson |
Statistician |
Vifor Pharma |
| Professor Christopher Jennison |
Statistics |
Bath University |
| Frank Miller |
Senior Statistician |
AstraZeneca |
| Robert Cuffe |
Principal Statistician, Infectious Diseases Medicine Development Centre |
GSK |
| Hans Ulrich Burger |
Biostatistics section leader |
Roche |
| Michael Richter |
Global Clinical Supply Coordinator |
Hoffman La-Roche |
| Hermann A. M. Mucke |
H.M. Pharma Consultancy |
previously Sanochemia Pharmazeutika and Sandoz |
| Marc Vandemeulebroecke |
Expert Statistician |
Novartis |
| Dr. Alan Eggleston |
Global Head of Sales & Marketing |
CMED (Clinical Research Services) LTD |
| Dr. Martin Kimber |
Clinical Trials Consultant |
Tessella PLC |
| Professor Dr. Gernot Wassmer |
Institute for Medical Statistics |
University of Cologne |